Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for the Diagnosis of External Ventricular and Lumbar Drainage-Associated Ventriculitis and Meningitis

by Lingye Qian, Yijun Shi, Fangqiang Li, Yufei Wang, Miao Ma, Yanfang Zhang, Yang W. Shao, Yang W. Shao, Guanghui Zheng, Guojun Zhang
Published 2020-12-01

JAK2 variations and functions in lung adenocarcinoma

by Yanjun Xu, Juan Jin, Jiawei Xu, Yang W Shao, Yun Fan
Published 2017-06-01

Short-Term Responders of Non–Small Cell Lung Cancer Patients to EGFR Tyrosine Kinase Inhibitors Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms

by Yanjun Xu, Xiaoling Tong, Junrong Yan, Xue Wu, Yang W. Shao, Yun Fan
Published 2018-12-01

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma

by Honghai Dai, Yang W. Shao, Xiaoling Tong, Xue Wu, Jiaohui Pang, Alei Feng, Zhe Yang
Published 2020-03-01

Variability of EGFR exon 20 insertions in 24 468 Chinese lung cancer patients and their divergent responses to EGFR inhibitors

by YanRu Qin, Hong Jian, Xiaoling Tong, Xue Wu, Fufeng Wang, Yang W. Shao, Xinmin Zhao
Published 2020-08-01

Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report

by Jianjun Ge, Bin Yao, Jia Huang, Xue Wu, Hua Bao, Qiuxiang Ou, Yang W. Shao, Jun Chen
Published 2019-06-01

Durable Complete Response to Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases and Low-Abundance EML4-ALK Variant in Liquid Biopsy: A Case Report

by Yingying Zhu, Ran Jia, Yang W. Shao, Liuqing Zhu, Qiuxiang Ou, Man Yu, Xue Wu, Yanbei Zhang
Published 2020-07-01

Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns.

by Xiangyuan Ma, Liangjun Zhu, Xue Wu, Hua Bao, Xiaonan Wang, Zhili Chang, Yang W Shao, Zhenxin Wang
Published 2017-01-01

Quantitative characterization of tumor cell-free DNA shortening

by Juntang Guo, Kefeng Ma, Hua Bao, Xiangyuan Ma, Yang Xu, Xue Wu, Yang W. Shao, Mei Jiang, Jin Huang
Published 2020-07-01

Clinical Benefit From a Combination of Brigatinib and Camrelizumab in Sarcomatoid Transformation of ALK-Rearranged Squamous Cell Lung Cancer Resistant to Crizotinib

by Wei Jiang, MD, Ruting Guan, PhD, Yang W. Shao, PhD, Bo Wang, PhD, Yina Wang, MD
Published 2020-06-01

Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes

by Junliang Lu, Ruoying Yu, Rui Liu, Xiaolong Liang, Jian Sun, Hui Zhang, Huanwen Wu, Zhiwen Zhang, Yang W. Shao, Junchao Guo, Zhiyong Liang
Published 2021-02-01

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling

by Zhanhong Chen, Tian Sun, Ziyan Yang, Yabing Zheng, Ruoying Yu, Xue Wu, Junrong Yan, Yang W Shao, Xiying Shao, Wenming Cao, Xiaojia Wang
Published 2020-02-01

Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma

by Hongyang Lu, Shifeng Yang, Huineng Zhu, Xiaoling Tong, Fajun Xie, Jing Qin, Na Han, Xue Wu, Yun Fan, Yang W. Shao, Weimin Mao
Published 2018-03-01

Clinical and molecular characteristics of Chinese non‐small cell lung cancer patients with ERBB2 transmembrane domain mutations

by Yun Fan, Jinrong Qiu, Ruoying Yu, Ran Cao, Xiaoxi Chen, Qiuxiang Ou, Xue Wu, Yang W. Shao, Misako Nagasaka, Jiexia Zhang, Sai‐Hong Ignatius Ou
Published 2020-08-01

Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer

by Yang W Shao, Yi-Long Wu, Xiao-Xiao Peng, Ruo-Ying Yu, Shu-Yu Wu, Can Pi, Zhi-Hong Chen, Xu-Chao Zhang, Cun-Yi Gao
Published 2020-06-01

SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients

by Zhu Mei, Yang W. Shao, Peinan Lin, Xiaomin Cai, Biao Wang, Yan Ding, Xiangyuan Ma, Xue Wu, Yewei Xia, Dongqin Zhu, Yongqian Shu, Zan Fu, Yanhong Gu
Published 2018-04-01

Combinatorial assessment of ctDNA release and mutational burden predicts anti‐PD(L)1 therapy outcome in nonsmall‐cell lung cancer

by Wenfeng Fang, Yuxiang Ma, Jiani C. Yin, Huaqiang Zhou, Fufeng Wang, Hua Bao, Ao Wang, Xue Wu, Shaodong Hong, Yunpeng Yang, Yan Huang, Hongyun Zhao, Yang W. Shao, Li Zhang
Published 2020-03-01

Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

by Yongsheng Wang, Feng Jiang, Ruixue Xia, Ming Li, Chengyun Yao, Yan Li, Hui Li, Qi Zhao, Mingke Shi, Yanzhe Yu, Yang W. Shao, Guoren Zhou, Hongping Xia, Liyun Miao, Hourong Cai
Published 2021-10-01

Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types

by Yongqian Shu, Xue Wu, Xiaoling Tong, Xiaonan Wang, Zhili Chang, Yu Mao, Xiaofeng Chen, Jing Sun, Zhenxin Wang, Zhuan Hong, Liangjun Zhu, Chunrong Zhu, Jun Chen, Ying Liang, Huawu Shao, Yang W. Shao
Published 2017-04-01